SEARCH

MEDIA PACK

NEWS

Current Edition

clinical trial

Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer

Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces that TG02 has passed the initial …

20 December 2017 news clinical trial immuno-oncology

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

SEARCH

MENU

Current Edition

Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer

Journal for Clinical Studies